Cargando…

Stimuli-responsive oligonucleotides in prodrug-based approaches for gene silencing

Oligonucleotides (ONs) have been envisaged for therapeutic applications for more than thirty years. However, their broad use requires overcoming several hurdles such as instability in biological fluids, low cell penetration, limited tissue distribution, and off-target effects. With this aim, many ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Debart, Françoise, Dupouy, Christelle, Vasseur, Jean-Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Beilstein-Institut 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827813/
https://www.ncbi.nlm.nih.gov/pubmed/29520308
http://dx.doi.org/10.3762/bjoc.14.32
_version_ 1783302540861898752
author Debart, Françoise
Dupouy, Christelle
Vasseur, Jean-Jacques
author_facet Debart, Françoise
Dupouy, Christelle
Vasseur, Jean-Jacques
author_sort Debart, Françoise
collection PubMed
description Oligonucleotides (ONs) have been envisaged for therapeutic applications for more than thirty years. However, their broad use requires overcoming several hurdles such as instability in biological fluids, low cell penetration, limited tissue distribution, and off-target effects. With this aim, many chemical modifications have been introduced into ONs definitively as a means of modifying and better improving their properties as gene silencing agents and some of them have been successful. Moreover, in the search for an alternative way to make efficient ON-based drugs, the general concept of prodrugs was applied to the oligonucleotide field. A prodrug is defined as a compound that undergoes transformations in vivo to yield the parent active drug under different stimuli. The interest in stimuli-responsive ONs for gene silencing functions has been notable in recent years. The ON prodrug strategies usually help to overcome limitations of natural ONs due to their low metabolic stability and poor delivery. Nevertheless, compared to permanent ON modifications, transient modifications in prodrugs offer the opportunity to regulate ON activity as a function of stimuli acting as switches. Generally, the ON prodrug is not active until it is triggered to release an unmodified ON. However, as it will be described in some examples, the opposite effect can be sought. This review examines ON modifications in response to various stimuli. These stimuli may be internal or external to the cell, chemical (glutathione), biochemical (enzymes), or physical (heat, light). For each stimulus, the discussion has been separated into sections corresponding to the site of the modification in the nucleotide: the internucleosidic phosphate, the nucleobase, the sugar or the extremities of ONs. Moreover, the review provides a current and detailed account of stimuli-responsive ONs with the main goal of gene silencing. However, for some stimuli-responsive ONs reported in this review, no application for controlling gene expression has been shown, but a certain potential in this field could be demonstrated. Additionally, other applications in different domains have been mentioned to extend the interest in such molecules.
format Online
Article
Text
id pubmed-5827813
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Beilstein-Institut
record_format MEDLINE/PubMed
spelling pubmed-58278132018-03-08 Stimuli-responsive oligonucleotides in prodrug-based approaches for gene silencing Debart, Françoise Dupouy, Christelle Vasseur, Jean-Jacques Beilstein J Org Chem Review Oligonucleotides (ONs) have been envisaged for therapeutic applications for more than thirty years. However, their broad use requires overcoming several hurdles such as instability in biological fluids, low cell penetration, limited tissue distribution, and off-target effects. With this aim, many chemical modifications have been introduced into ONs definitively as a means of modifying and better improving their properties as gene silencing agents and some of them have been successful. Moreover, in the search for an alternative way to make efficient ON-based drugs, the general concept of prodrugs was applied to the oligonucleotide field. A prodrug is defined as a compound that undergoes transformations in vivo to yield the parent active drug under different stimuli. The interest in stimuli-responsive ONs for gene silencing functions has been notable in recent years. The ON prodrug strategies usually help to overcome limitations of natural ONs due to their low metabolic stability and poor delivery. Nevertheless, compared to permanent ON modifications, transient modifications in prodrugs offer the opportunity to regulate ON activity as a function of stimuli acting as switches. Generally, the ON prodrug is not active until it is triggered to release an unmodified ON. However, as it will be described in some examples, the opposite effect can be sought. This review examines ON modifications in response to various stimuli. These stimuli may be internal or external to the cell, chemical (glutathione), biochemical (enzymes), or physical (heat, light). For each stimulus, the discussion has been separated into sections corresponding to the site of the modification in the nucleotide: the internucleosidic phosphate, the nucleobase, the sugar or the extremities of ONs. Moreover, the review provides a current and detailed account of stimuli-responsive ONs with the main goal of gene silencing. However, for some stimuli-responsive ONs reported in this review, no application for controlling gene expression has been shown, but a certain potential in this field could be demonstrated. Additionally, other applications in different domains have been mentioned to extend the interest in such molecules. Beilstein-Institut 2018-02-19 /pmc/articles/PMC5827813/ /pubmed/29520308 http://dx.doi.org/10.3762/bjoc.14.32 Text en Copyright © 2018, Debart et al. https://creativecommons.org/licenses/by/4.0https://www.beilstein-journals.org/bjoc/termsThis is an Open Access article under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The license is subject to the Beilstein Journal of Organic Chemistry terms and conditions: (https://www.beilstein-journals.org/bjoc/terms)
spellingShingle Review
Debart, Françoise
Dupouy, Christelle
Vasseur, Jean-Jacques
Stimuli-responsive oligonucleotides in prodrug-based approaches for gene silencing
title Stimuli-responsive oligonucleotides in prodrug-based approaches for gene silencing
title_full Stimuli-responsive oligonucleotides in prodrug-based approaches for gene silencing
title_fullStr Stimuli-responsive oligonucleotides in prodrug-based approaches for gene silencing
title_full_unstemmed Stimuli-responsive oligonucleotides in prodrug-based approaches for gene silencing
title_short Stimuli-responsive oligonucleotides in prodrug-based approaches for gene silencing
title_sort stimuli-responsive oligonucleotides in prodrug-based approaches for gene silencing
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827813/
https://www.ncbi.nlm.nih.gov/pubmed/29520308
http://dx.doi.org/10.3762/bjoc.14.32
work_keys_str_mv AT debartfrancoise stimuliresponsiveoligonucleotidesinprodrugbasedapproachesforgenesilencing
AT dupouychristelle stimuliresponsiveoligonucleotidesinprodrugbasedapproachesforgenesilencing
AT vasseurjeanjacques stimuliresponsiveoligonucleotidesinprodrugbasedapproachesforgenesilencing